Fusion Antibodies Ltd (FAB) ORD GBP0.04

- Add to watchlist
- Create an alert
- This stock can be held in a




15.00p
15.50p
20.50p
£16.48 million
15.00p
14.00p
3.85p
n/a
0.50p (3.45%) Previous:
0.50p
443,354
n/a
30,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/03/2025 | 31/03/2024 |
---|---|---|
Revenue (£m) | 1.96 | 1.14 |
Profit before tax (£m) | (1.78) | (2.29) |
Adjusted EPS (p): | (1.80) | (3.90) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Fusion Antibodies expecting stronger second-half performance
16 October 2025 15:42
-
Fusion Antibodies reports further validation of OptiMAL platform
17 September 2025 09:42
-
Fusion Antibodies selected for follow-on projects
27 August 2025 08:10
-
Result of AGM
16 October 2025 13:31
-
AGM statement and H1 trading update
16 October 2025 07:00
-
Contract win
8 October 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.